The assessment of proliferating cell nuclear antigen immunostaining in myelodysplastic syndromes and its prognostic significance.

European journal of histochemistry : EJH

Volumn 49, Issue 1, 2005, Pages 27-32

  Alexandrakis, M G ^a   Passam, F H ^a   Dambaki, K ^a   Passam, A M ^a   Nalbanti, F ^a   Stathopoulos, E S ^a   Kyriakou, D S ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; BLOOD; BONE MARROW CELL; CELL PROLIFERATION; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; MYELODYSPLASTIC SYNDROME; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; PROSPECTIVE STUDY; STAINING; SURVIVAL;

AGED; AGED, 80 AND OVER; BONE MARROW CELLS; CELL PROLIFERATION; FEMALE; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROSPECTIVE STUDIES; STAINING AND LABELING; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

MLCS; MLOWN;

EID: 20344364160     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: 10.4081/923     Document Type: Article

References (0)